Similar to the findings in NSCLC cell line, PFN2 OE increased Smad2 and Smad3 expression, whereas PFN2 knockdown inhibited the expression (Figure 7A, 7B). The gene discussed is PFN2; the disease is non-small cell lung carcinoma.